Loading...
Liposarcoma: multimodality management and future targeted therapies
There are three biologic groups of liposarcoma: well- and dedifferentiated liposarcoma (WD/DDLS), myxoid/round cell liposarcoma (M/RCLS) and pleomorphic liposarcoma. WD/DDLS is characterized by amplification of 12q13-15 (including the oncogenes MDM2 and CDK4), M/RCLS by FUS-DDIT3 translocations, and...
Na minha lista:
| Udgivet i: | Surg Oncol Clin N Am |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5010855/ https://ncbi.nlm.nih.gov/pubmed/27591497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.soc.2016.05.007 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|